SARS-CoV-2 Antigen kit
-
SARS-CoV-2 Antigen Rapid Test（nasal）
REF 500200 Specification 1 Tests/Box ；5 Tests/box ； 20 Tests/box Detection principle Immunochromatographic assay Specimens Anterior nasal swab Intended Use StrongStep® SARS-CoV-2 Antigen Rapid Test Cassette employs immunochromatography technology to detect the SARS- CoV-2 nucleocapsid antigen in human anterior nasal swab specimen. This testis single use only and intended for self-testing. It is recommanded to use this test within 5 days of symptom onset. It is supported by the clinical performance assessment. -
SARS-CoV-2 Antigen Rapid Test（Professional Use）
REF 500200 Specification 25 Tests/box Detection principle Immunochromatographic assay Specimens Anterior nasal swab Intended Use StrongStep® SARS-CoV-2 Antigen Rapid Test Cassette employs immunochromatography technology to detect the SARS- CoV-2 nucleocapsid antigen in human anterior nasal swab specimen. This testis single use only and intended for self-testing. It is recommanded to use this test within 5 days of symptom onset. It is supported by the clinical performance assessment. -
SARS-CoV-2 Antigen Rapid Test for Saliva
REF 500230 Specification 20 Tests/Box Detection principle Immunochromatographic assay Specimens SalivaIntended Use This is a rapid immunochromatographic assay for the detection of SARS-CoV-2 virus Nucleocapsid Protein antigen in human Saliva swab collected from individuals who are suspected of COVID-19 by their healthcare provider within the first five days of the onset of symptoms. The assay is used as an aid in the diagnosis of COVID-19. -
System Device for SARS-CoV-2 & Influenza A/B Combo Antigen Rapid Test
REF 500220 Specification 20 Tests/Box Detection principle Immunochromatographic assay Specimens Nasal / Oropharyngeal swab Intended Use This is a rapid immunochromatographic assay for the detection of SARS-CoV-2 virus Nucleocapsid Protein antigen in human Nasal/Oropharyngeal swab collected from individuals who are suspected of COVID-19 by their healthcare provider within the first five days of the onset of symptoms. The assay is used as an aid in the diagnosis of COVID-19. -
Dual Biosafety System Device for SARS-CoV-2 Antigen Rapid Test
REF 500210 Specification 20 Tests/Box Detection principle Immunochromatographic assay Specimens Nasal / Oropharyngeal swab Intended Use This is a rapid immunochromatographic assay for the detection of SARS-CoV-2 virus Nucleocapsid Protein antigen in human Nasal /Oropharyngeal swab collected from individuals who are suspected of COVID-19 by their healthcare provider within the first five days of the onset of symptoms. The assay is used as an aid in the diagnosis of COVID-19.
